Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

4.2 Abstract in Atti di convegno: [281] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 101 a 120 di 281
Titolo Data di pubblicazione Autore(i) File
Transplacental carcinogenesis: state of the art 1-gen-2002 Ferrandina, G; Salutari, V; Legge, F; Scambia, G
Celecoxib plus carboplatin in heavily pre-treated patients with recurrent ovarian carcinoma: preliminary results of a phase II study 1-gen-2005 Ferrandina, G; Legge, F; Gallotta, V; Lorusso, D; Testa, Ac; Salutari, V; Paglia, A; Col angelo, M; Fulfaro, F; Scambia, G
New insights in biological characterization of ovarian cancer 1-gen-2008 Legge, F; Ferrandina, G; D’Asta, M; Carone, V; Licameli, A; Scambia, G
Clinical role of Cyclooxygenase-2 (COX-2) expression in tumor and stromal component of cervical cancer 1-gen-2002 Ferrandina, G; Lauriola, L; Legge, F; Zannoni, Gf; Gessi, M; Maggiano, N; Salutari, V; Mancuso, S; Ranelletti, Fo; Scambia, G
Cyclooxygenase-2 (COX-2) inhibition is associated with increased proportion of Tumor Infiltrating Lymphocytes (TIL) expressing the zeta chain of T-Cell Receptor (TCR) in human cervical cancer 1-gen-2006 Ferrandina, G; Legge, F; Ranelletti, Fo; Martinelli, E; Salutari, V; Fattorossi, A; Zannoni, G; Gallotta, V; Vellone, V; Paglia, A; Scambia, G
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer 1-gen-2004 Ferrandina, G; Ranelletti, Fo; Legge, F; Gessi, M; Salutari, V; Distefano, Mg; Zannoni, Gf; Gallotta, V; Martinelli, E; Mancuso, S; Scambia, G
Targeted therapies in gynecological cancers 1-gen-2006 Legge, F; Ferrandina, G; Scambia, G
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome 1-gen-2008 Legge, F; Petrillo, M; Adamo, V; Pisconti, S; Scambia, G; Ferrandina, G
Nuovi Fattori Biologici di Prognosi nel Carcinoma dell'Endometrio 1-gen-2001 Ferrandina, G; Ranelletti, Fo; Ercoli, A; Lauriola, L; Legge, F; Zannoni, Gf; Mancuso, S; Scambia, G
Angiogenesis inhibitors in gynecological cancers 1-gen-2003 Ferrandina, G; Legge, F; Gallotta, V; Salutari, V; Scambia, G
Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, modulates cytokines levels in serum of cervical cancer patients 1-gen-2004 Legge, F; Salutari, V; Martinelli, E; Ranelletti, Fo; Gallotta, V; Lorusso, D; Mancuso, S; Scambia, G; Ferrandina, G
Proposal of a prognostic score in combined modality treatment of locally advanced carcinoma of the uterine cervix 1-gen-2008 Macchia, G; Smaniotto, D; Luzi, S; Forni, F; Mignogna, S; Lorusso, D; Legge, F; Picardi, V; Cocciolo, A; Romito, S; Ferrandina, G; Scambia, G; Valentini, V; Cellini, N; Morganti, Ag
Analysis of survivin expression in ovarian cancer and its correlation with clinical, surgical, pathological and apoptosis-related parameters 1-gen-2004 Ferrandina, G; Legge, F; Martinelli, E; Gessi, M; Gallotta, V; Salutari, V; Zannoni, Gf; Ranelletti, Fo; Scambia, G
The peritoneal cavity: tumor metastasis and growth 1-gen-2006 Legge, F; Ferrandina, G; Fagotti, A; Scambia, G
Cyclooxygenase-2 (COX-2) expression in non neoplastic (NNED) and  neoplastic vulvar epithelial disorders 1-gen-2003 Ferrandina, G; Ranelletti, Fo; Lauriola, L; Zannoni, Gf; Legge, F; Gessi, M; Salutari, V; Scambia, G
Targeted therapy for ovarian cancer 1-gen-2004 Legge, F; Ferrandina, G; Scambia, G
Radical surgery (RS) plus intraperitoneal hyperthermic perfusion (IPHP) with oxaliplatin followed by intravenous docetaxel in the treatment of peritoneal carcinosis from platinum-sensitive recurrent ovarian cancer (OC): A pilot study 1-gen-2007 Fagotti, A; Ferrandina, G; Paris, I; Mari, A; Legge, F; Fanfani, F; Facchini, G; Scambia, G
Magnetic resonance imaging of pelvic endometriosis. Effect of reader's experience on accuracy and interobserver variability 1-gen-2009 Restaino, G; Missere, M; Maselli, G; Mattioni, O; Calandriella, L; Carone, V; Legge, F; Ferandina, G; Sallustio, G
Endometriosis and Cancer 1-gen-2009 Legge, F; Paglia, A; D’Asta, M; Carone, V; Scambia, G; Ferrandina, G
Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer 1-gen-2006 Ferrandina, G; Ludovisi, M; D’Agostino, G; Naldini, A; Lorusso, D; Testa, Ac; Legge, F; Salutari, V; Scambia, G
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 101 a 120 di 281
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 4 Contributo in Atti di Convegno ...281
Autore
  • SIMONETTI, VALENTINA55
  • LEGGE, FRANCESCO36
  • D'ADAMO, MARIA CRISTINA 31
  • FRATANTONIO, DEBORAH 22
  • PERRINI, SEBASTIO15
  • IACOVIELLO, LICIA14
  • MOLA, MARIA GRAZIA12
  • BUSSOLI, CANDIDA11
  • VINCIGUERRA, MANLIO11
  • OXILIA, GREGORIO9
Data di pubblicazione
  • 2020 - 202558
  • 2010 - 2019137
  • 2000 - 200967
  • 1990 - 199918
  • 1987 - 19891
Editore
  • Accademia Italiana di Economia Az...2
  • Elsevier2
  • Elsevier-Frontiers2
  • World Business Institute2
  • B.S.LAB1
  • Diamond Scientific Publishing1
  • Edizioni MAF Servizi1
  • Elsevier- ScienceDirect1
  • Firenze University Press1
  • OXFORD UNIV PRESS1
Rivista
  • ACTA PHYSIOLOGICA7
  • BIOPHYSICAL JOURNAL7
  • JOURNAL OF HEPATOLOGY6
  • JOURNAL OF CLINICAL ONCOLOGY5
  • THROMBOSIS RESEARCH5
  • THROMBOSIS AND HAEMOSTASIS4
  • GIORNALE ITALIANO DI NEFROLOGIA3
  • INTERNATIONAL JOURNAL OF GYNECOLO...3
  • JOURNAL OF THE AMERICAN SOCIETY O...3
  • SCHIZOPHRENIA BULLETIN3
Keyword
  • AQP43
  • oral health3
  • TRPV43
  • C. elegans2
  • Dentistry2
  • Engagement2
  • Italy2
  • juvenile2
  • mitochondria2
  • N.A2
Lingua
  • eng126
  • ita18
Accesso al fulltext
  • no fulltext281